Daily non-political popular news in brief.

Chemical chaperone could open door to treatment of neurological disorder

An unexpected finding turned out to be a clue leading researchers at Washington University School of Medicine in St. Louis to propose a new treatment approach for Niemann-Pick disease, a rare, deadly neurodegenerative disorder. They believe the approach also could be useful for more common diseases -- such as cystic fibrosis -- that stem from a similar type of defect.

Read more »

Keywords: chemical, chaperone, open, door, treatment, neurological, disorder

« Previous | Next »

Similar news on "Chemical chaperone could open door to treatment of neurological disorder":

1. New insight about the source of anxiety in Rett syndrome
   11-13-2006 · EurekAlert!
   A peptide known to play a role in anxiety is overly plentiful in a mouse model of the inherited neurological disorder Rett syndrome and appears to underlie the anxiety-like behavior in these mice. The finding could provide a clue to treatment for this symptom.
   Similar news · Read more »
   
2. Lisdexamfetamine dimesylate in ADHD phase 3 data presented
   10-27-2006 · EurekAlert!
   Shire and New River Pharmaceuticals Inc. announce that their investigational ADHD treatment, lisdexamfetamine dimesylate, also known as NRP104 or LDX, yielded a 60 percent improvement in the primary rating scale scores for symptoms of Attention-Deficit/Hyperactivity Disorder in children aged 6 to 12 years who received six months of treatment in an open-label phase 3 study presented at a national meeting of child and adolescent psychiatrists.
   Similar news · Read more »
   
3. New genetic variants associated with lipid levels, risk for coronary artery disease
   01-13-2008 · EurekAlert!
   In research supported primarily by the National Institutes of Health, scientists have discovered more than 25 genetic variants in 18 genes connected to cholesterol and lipid levels. Seven of the 18 genes previously had not been connected, while the 11 others confirm previous discoveries. The study will appear online Jan. 13 in Nature Genetics. These variants potentially open the door to strategies for the treatment and prevention of CAD.
   Similar news · Read more »
   
4. Scientists find one reason why bladder cancer hits more men
   04-20-2007 · EurekAlert!
   Scientists have discovered one of the reasons why bladder cancer is so much more prevalent in men than women: A molecular receptor or protein that is much more active in men than women plays a role in the development of the disease. The finding could open the door to new types of treatment with the disease.
   Similar news · Read more »
   
5. Eculizumab is well-tolerated and shows significant improvement in PNH patients (Ph III)
   12-09-2006 · EurekAlert!
   Eculizumab, a MAb drug, appeared safe and well-tolerated, and provided clinically and statistically significant improvements in intravascular hemolysis, anemia, fatigue and quality of life in patients with paroxysmal nocturnal hemoglobinuria (PNH) in a Phase 3 open-label, 52 weeks of treatment trial. PNH is a rare and life-threatening form of hemolytic anemia and acquired genetic blood disorder, and patients lack naturally-occurring complement inhibitors on the surface of their red blood cells.
   Similar news · Read more »
   
6. Stem cells show promise for treating Huntington's disease
   09-25-2007 · EurekAlert!
   Paying close attention to how a canary learns a new song has helped scientists open a new avenue of research against Huntington's disease -- a fatal disorder for which there is currently no cure or even a treatment to slow the disease. Scientists used gene therapy to guide the development of endogenous stem cells in the brains of mice affected by a form of Huntington’s, generating new medium spiny neurons -- the cell lost in Huntington's disease.
   Similar news · Read more »
   
7. Brain images show hysteria not an imaginary disorder
   12-11-2006 · EurekAlert!
   In what's being called a novel finding, researchers using brain scans have uncovered evidence of cerebral dysfunction in women with sensory conversion disorder, better known as hysteria. The study's findings open up a new window to understanding hysteria, an unexplained neurological disorder in which a patient complains of symptoms, but doctors can't find anything medically wrong with them. The study is published in the December 12, 2006, issue of the journal Neurology.
   Similar news · Read more »
   
8. Animal study identifies potential treatment for Huntington's disease
   10-08-2007 · EurekAlert!
   Mass. General Institute for Neurodegererative Disorders researchers have identified a compound that may lead to a treatment that could protect against the effects of Huntington's Disease. Their report describes how a small molecule called C2-8 appears to delay the loss of motor control and reduce neurological damage in a mouse model of the disorder.
   Similar news · Read more »
   
9. Early treatment stops epilepsy in its tracks
   12-13-2007 · EurekAlert!
   It is possible to suppress the development of epilepsy in genetically predisposed animals, which could open the door to treating epilepsy as a preventable disease.
   Similar news · Read more »
   
10. Proteases cause pain in irritable bowel syndrome
    02-15-2007 · EurekAlert!
    Irritable bowel syndrome (IBS) is a common gastrointestinal disorder in the developed world. It is characterized by altered bowel function, abdominal discomfort, and pain. However, there are few effective treatments for IBS, in part because the molecular mechanisms underlying the disease symptoms have not been well defined. But now, researchers from the University of Calgary have provided evidence that serine proteases and PAR2 might provide new therapeutic targets for the treatment of IBS.
    Similar news · Read more »